September 10, 2025 | 06:56 pm
TEMPO.CO, Jakarta - Indonesia's Health Ministry is responding to the launch of a new cancer treatment developed by Russian scientists. Health Minister Budi Gunadi has already communicated with the manufacturer.
"I have heard about it and have also spoken with several companies that produce it," Budi said at the Health Ministry building in Jakarta on Tuesday, September 9, 2025.
Budi explained that Entromix, the treatment developed by Russia, is more accurately classified as a drug, though its testing method is similar to a vaccine's. He noted that the Indonesian government is interested in understanding it better.
As a result, a special team has been sent to assess if Indonesia would be a suitable location for one of the clinical trial sites. "Currently, the cancer drug is undergoing a clinical trial," said Budi.
Breakthrough in Cancer Treatment
Previously, Russia's mRNA-based cancer treatment, Enteromix, was reported to have shown 100% effectiveness and safety in clinical trials. These results are seen as a major breakthrough, offering new hope in the fight against aggressive cancer and its development.
"The Russian Enteromix cancer vaccine is now ready for clinical use," according to a statement from the Federal Medical and Biological Agency (FMBA), as reported by The Times of India on September 9, 2025.
FMBA Head Veronica Skvortsova stated that the mRNA-based treatment has successfully passed preclinical trials, proving to be both safe and effective. The treatment has shown significant results in shrinking tumors, slowing their growth, and is safe for repeated use.
The drug was developed by the National Medical Research Radiological Center of the Ministry of Health of Russia in collaboration with the Engelhardt Institute of Molecular Biology (EIMB) of the Russian Academy of Sciences (RAS). They have tested the treatment on 48 people.
According to a report from MedPath, Enteromix uses four harmless viruses to attack and destroy tumors while also strengthening the immune system. After years of testing, the treatment has been proven capable of slowing down cancer growth and, in some cases, completely destroying it.
The next step is awaiting regulatory approval. If successful, Enteromix would become the first personalized mRNA cancer treatment available to the public.
Defara contributed to the report
Editor’s Choice: Russia's Enteromix Cancer Vaccine Reports 100% Success in Clinical Trials
Click here to get the latest news updates from Tempo on Google News
After Indonesia, One Piece Flags Fly Amidst Nepal Anti-Government Protests
1 jam lalu
Demonstrators oppose censorship, corruption, and the leadership of Nepal's Prime Minister K.P. Sharma Oli.
Indonesia Gears Up for October Clashes with Saudi, Iraq in World Cup 2026 Qualifiers
4 jam lalu
Indonesia will face Saudi Arabia and Iraq in the fourth round of the 2026 World Cup Qualifiers in Group B Asia Zone in October. Here's the schedule.
Preventing and Treating Cervical, Vulvar, and Vaginal Cancers: What You Need to Know
9 jam lalu
Article discussing the prevention and treatment of vulvar and vaginal cancers, including HPV vaccination, regular screening, and medical care.
Prabowo Orders Acceleration of National Priority Programs Implementation
9 jam lalu
Indonesian President Prabowo Subianto has instructed the acceleration of all programs' implementation without any obstacles due to paperwork reasons.
Indonesia's DPR Aims to Complete Asset Seizure Bill This Year
10 jam lalu
Indonesian House of Representatives (DPR) aims to complete the Asset Seizure Bill, or RUU Perampasan Aset, this year.
Gerald Vanenburg Comments on Failing to Qualify Indonesian U-23 for Asian Cup
11 jam lalu
The U-23 Indonesia national team failed to qualify for the AFC U-23 Asian Cup 2026 after losing 0-1 to South Korea. Gerald Vanenburg reveals some obstacles.
Indonesia to Launch 6 New Special Economic Zones, Including First Halal SEZ
19 jam lalu
The government plans to leverage it to position Indonesia as a significant player in the global halal industry supply chain.
Indonesia U-23 Falls to South Korea, Misses Asian Cup Qualification
21 jam lalu
The Indonesian U-23 failed to qualify for the 2026 U-23 Asian Cup after being defeated by South Korea in the final match of Group J.
Russia's Enteromix Cancer Vaccine Reports 100% Success in Clinical Trials
1 hari lalu
A Russian-made mRNA cancer vaccine, Enteromix, is reported to show 100% efficacy and safety in clinical trials, marking a breakthrough in the fight against aggressive cancer and its prevention.
A Death in Jakarta: Police Violence and the Crisis of Accountability
1 hari lalu
The killing of a young food delivery driver by a police armoured vehicle has reignited debate over police brutality in Indonesia.
